Source: EIN Presswire

Press Release: Shuwen : Shuwen Biotech Announce Agreement with Devyser to Commercialize Breast Cancer Tests in China

Shuwen Biotech will distribute, and offer testing services with, Devyser's BRCA NGS and other oncology kits in China DEQING, CHINA, March 7, 2022 /⁨EINPresswire.com⁩/ -- Shuwen Biotech, an integrated in vitro diagnostic company with focuses on breast ...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Jay Z. Zhang's photo - Chairman & CEO of Shuwen

Chairman & CEO

Jay Z. Zhang

CEO Approval Rating

90/100

Read more